We evaluated serum levels of 17 cytokines and 5 adhesion molecules in patients treated for acute myeloid leukemia (AML). Our results indicate that serum levels of specific analytes (IL-7, EGF, VEGF, E-selectin) are significantly altered in patients treated for AML, reflecting activity of the disease.